Ex-Genentech Employees' Denali Breaks 2017 IPO Records, Raises $250M Post author:Sam Post published:December 7, 2017 Post category:BioPharma With the raise, the company’s market valuation is currently $1.7B. Source: BioSpace You Might Also Like Scandal-Ridden INSYS Replaced 90% of Its Original Sales Force in Makeover October 8, 2017 Heads Up Startups: Silicon Valley VC Firm—With an Appetite for Biotech—Nabs Record $800 Million Fund July 25, 2017 Biogen and AbbVie Voluntarily Pull Multiple Sclerosis Drug Off the Market March 1, 2018
Heads Up Startups: Silicon Valley VC Firm—With an Appetite for Biotech—Nabs Record $800 Million Fund July 25, 2017
